CASE REPORT : PREECLAMPSIA
DOI:
https://doi.org/10.31004/jkt.v6i2.43038Keywords:
Preeclampsia, Clinical Manifestations, Pharmacology TherapyAbstract
Preeklamsia merupakan suatu kelainan pada kehamilan yang ditandai dengan peningkatan tekanan darah atau hipertensi disertai proteinuria yang terjadi pada usia kehamilan lebih dari 20 minggu pada wanita yang awalnya memiliki tekanan darah normal. Prevalensi preeklamsia sekitar 5% - 15% dari seluruh ibu hamil. Hal ini dapat menimbulkan komplikasi berat bahkan kematian pada ibu dan janin apabila tidak ditangani dengan baik. Presentasi kasus: Seorang wanita berusia 50 tahun dengan tinggi badan pasien 145 cm, berat badan pasien 50 kg dan IMT 23,7, dirawat di rumah sakit dengan diagnosis GIII P2002 37/38 GHHIU + PE + IUGR/IUGR. Tekanan darah pasien 177/102 mmHg dengan RR 19x/menit, suhu tubuh 36,6OC, dan SO2 98% serta kadar Hb 7,2 g/dL, HCT 23,8%, MCV 72,3 fl, MCH 21,9, SCr 0,51mg/dL, BUN 6mg/dL, Kalium 3,4mmol/l, Albumin 3,23g/dL. Pasien tidak memiliki riwayat hipertensi, diabetes melitus, alergi dan asma. Riwayat pemeriksaan pasien pada usia kehamilan 35/36 minggu dimana pasien USG, kemudian didapatkan hasil fetus yang diduga IUGR dan memerlukan NICU sehingga pasien diberikan surat rujukan. Kesimpulan: Berdasarkan pharmaceutical care, pemberian terapi pada pasien sudah sesuai dengan pedoman. Pada pasien dengan preeklamsia, diagnosis yang tepat serta penanganan dan penatalaksanaan yang tepat oleh tim multidisiplin dapat mencegah komplikasi preeklamsia dan meningkatkan hasil pengobatan pasien preeklamsia.References
Ali, S., Athar, M., & Ahmed, S. M. (2019). Basics of CPB. Indian Journal of Anaesthesia, 49(4), 257–262. https://doi.org/10.4103/ija.IJA
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019). Pre-eclampsia: pathophysiology and clinical implications. The BMJ, 366, 1–15. https://doi.org/10.1136/bmj.l2381
Gathiram, P., & Moodley, J. (2016). Pre-eclampsia: Its pathogenesis and pathophysiolgy. Cardiovascular Journal of Africa, 27(2), 71–78. https://doi.org/10.5830/CVJA-2016-009
Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., & Torloni, M. R. (2018). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews, 2018(10). https://doi.org/10.1002/14651858.CD001059.pub5
Jain, V. (2015). Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. Journal of Obstetrics and Gynaecology Canada, 37(9), 774–775. https://doi.org/10.1016/S1701-2163(15)30145-6
Jasiecka, A., Mas̈lanka, T., & Jaroszewski, J. J. (2014). Pharmacological characteristics of metamizole. Polish Journal of Veterinary Sciences, 17(1), 207–214. https://doi.org/10.2478/pjvs-2014-0030
Kahar, L. A., Wiwi Monika Sari, & Mentari Faisal Putri. (2023). Intensive Care Management of Preeclampsia: A Case Report. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 7(8), 3528–3532. https://doi.org/10.37275/bsm.v7i8.853
Kosim, M. S. (2016). Gawat Darurat Neonatus pada Persalinan Preterm. Sari Pediatri, 7(4), 225. https://doi.org/10.14238/sp7.4.2006.225-31
Madhusudhan, S. K. (2013). Novel analgesic combination of tramadol, paracetamol, caffeine and taurine in the management of moderate to moderately severeacute low back pain. Journal of Orthopaedics, 10(3), 144–148. https://doi.org/10.1016/j.jor.2013.07.001
McCracken, G., Houston, P., & Lefebvre, G. (2008). Guideline for the Management of Postoperative Nausea and Vomiting. Journal of Obstetrics and Gynaecology Canada, 30(7), 600–607. https://doi.org/10.1016/S1701-2163(16)32895-X
Novikova, N., Hofmeyr, G. J., & Cluver, C. (2015). Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews, 2015(6), 1–62. https://doi.org/10.1002/14651858.CD007872.pub3
Peres, G. M., Mariana, M., & Cairrão, E. (2018). Pre-eclampsia and eclampsia: An update on the pharmacological treatment applied in Portugal. Journal of Cardiovascular Development and Disease, 5(1). https://doi.org/10.3390/jcdd5010003
POGI. (2016). PNPK Diagnosis dan Tatalaksana Preeklampsia. 1–48.
Poon et al. (2017). A Pragmatic Guide for First Trimester Screening and Prevention. Physiology & Behavior, 176(12), 139–148. https://doi.org/10.1002/ijgo.12802.
Redman, C. W. (1976). The management of severe pre-eclampsia. Midwife, Health Visitor & Community Nurse, 12(10), 322–325.
Sekhavat, L., Firouzabadi, R. D., & Karbasi, S. A. (2011). Comparison of interval duration between single course antenatal corticosteroid administration and delivery on neonatal outcomes. Journal of the Turkish German Gynecology Association, 12(2), 86–89. https://doi.org/10.5152/jtgga.2011.21
Shahid, A., & Khan, A. (2013). Tranexamic acid in decreasing blood loss during and after caesarean section. Journal of the College of Physicians and Surgeons Pakistan, 23(7), 459–462. https://doi.org/07.2013/JCPSP.459462
Szczepiorkowski, Z. M., & Dunbar, N. M. (2013). Transfusion guidelines: when to transfuse. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2013, 638–644. https://doi.org/10.1182/asheducation-2013.1.638
Than, N. G., Romero, R., Tarca, A. L., Kekesi, K. A., Xu, Y., Xu, Z., Juhasz, K., Bhatti, G., Leavitt, R. J., Gelencser, Z., Palhalmi, J., Chung, T. H., Gyorffy, B. A., Orosz, L., Demeter, A., Szecsi, A., Hunyadi-Gulyas, E., Darula, Z., Simor, A., … Papp, Z. (2018). Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia. Frontiers in Immunology, 9(AUG). https://doi.org/10.3389/fimmu.2018.01661
Vary, E. P. (2015). Blood transfusion. Surgery, 7(2), 282–309. https://doi.org/10.7748/en.4.4.10.s3
Zeitoun, A. (2011). Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World Journal of Gastrointestinal Pharmacology and Therapeutics, 2(4), 27. https://doi.org/10.4292/wjgpt.v2.i4.27
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ade Giriayu Anjani, Nadia Pramasari, Yogi Bhakti Marhenta
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
